Abstract:Stem cells hold great potential for the regenerative medicine and tissue engineering. Controlling the fate of stem cell in a reliable method still remains a problem. The strategies for directing the fate of stem cells include biophysical cues (e.g. matrix stiffness, topography, and extracellular forces), biochemical cues (e.g. growth factors, cytokines and chemokines) and cellular reprogramming (e.g. gene delivery). Controlled delivery of specific genes, such as transcription factor encoding genes, to stem cells is a promising strategy for stem-cell based therapy. Gene delivery methods include two major categories: viral vectors and non-viral vectors. Non-viral gene delivery vectors hold great promise for gene therapy due to the safety concerns with viral vectors. However, the application of non-viral vectors is hindered by their low transfection efficiency. Herein, in order to tackle this challenge, we endeavored to develop non-viral vectors with efficient gene delivery and low toxicity to hard-to-transfect MSCs. First, we focused on the identification and characterization of novel MSCs-targeting peptides using phage libraries. A peptide (VTAMEPGQ) that can home to rat mesenchymal stem cells (rMSCs) was identified. This VTAMEPGQ peptide demonstrated high affinity and specificity to rMSCs. When integrated into liposome protamine/DNA lipoplex (LPD) system, the peptide significantly enhanced gene transfection efficiency to rMSCs. Second, we focused on developing efficiently and chemically-defined LPD-based gene delivery system to rMSCs. We employed three-folds reiterated VTAMEPGQ peptides, nuclear localization signal and liposome/protamine complex to delivery vascular endothelial growth factor (VEGF) reporter gene to rMSCs. The developed LPD gene delivery complex demonstrated high transfection efficiency and long-lasting gene expression profile. Third, we developed Glutathione (GSH) cleavable magnetic/silica nanoclusters integrating MSC-homing major coat protein (pVIII) for targeted gene delivery. pVIII proteins were purified from the VTAMEPGQ-sequence bearing phage identified by phage display technique. The intracellular GSH is responsible for cleaving the S-S bond to dissociate the nanoclusters to release DNA. The as-synthesized gene delivery complex also showed satisfactory gene transfection result to rMSCs. Finally, we studied the role of cell-binding peptides in directing the stem cell differentiation. We take advantage of the three peptides, which are selected by phage display and show different binding affinities against MSCs, to investigate the osteogenic differentiation of MSCs. Surprisingly, we discovered that the peptide (VTAMEPGQ) with the highest MSC-binding affinity induced the osteogenic differentiation of MSCs most efficiently. We propose that the MSC-binding peptides may bind to the bone morphometric protein (BMP) receptors to initiate the osteogenic differentiation pathway.

Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells.

TARGETED GENE DELIVERY TO MESENCHYMAL STEM CELLS USING NANOPARTICLES

Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic

CREDVW-Linked Polymeric Micelles As a Targeting Gene Transfer Vector for Selective Transfection and Proliferation of Endothelial Cells.

Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy

Multifunctional Gene Carriers with Enhanced Specific Penetration and Nucleus Accumulation to Promote Neovascularization of HUVECs in Vivo

Plasmid-encapsulated Polyethylene Glycol-Grafted Polyethylenimine Nanoparticles for Gene Delivery into Rat Mesenchymal Stem Cells

Mixed Micelles Obtained by Co-Assembling Comb-Like and Grafting Copolymers As Gene Carriers for Efficient Gene Delivery and Expression in Endothelial Cells

Nonviral Gene Targeting at Rdna Locus of Human Mesenchymal Stem Cells

Mesenchymal Stem Cells As a Novel Carrier for Targeted Delivery of Gene in Cancer Therapy Based on Nonviral Transfection.

Pvegf-Loaded Lipopolysaccharide-Amine Nanopolymersomes for Therapeutic Angiogenesis.

Multi-targeting peptides for gene carriers with high transfection efficiency

Polyethylenimine 600-Β-cyclodextrin : a Promising Nanopolymer for Nonviral Gene Delivery of Primary Mesenchymal Stem Cells

Multitargeting Gene Delivery Systems for Enhancing the Transfection of Endothelial Cells

High Efficiency Intracellular Transport of Cationic Peptide Stearate for Gene Delivery in Tumor Cells and Multipotent Stem Cells

Synergetic Targeted Delivery of Sleeping‐Beauty Transposon System to Mesenchymal Stem Cells Using LPD Nanoparticles Modified with a Phage‐Displayed Targeting Peptide

Peptide Functionalized Biomimetic Gene Complexes Enhance Specificity for Vascular Endothelial Regeneration

Minicircle microporation-based non-viral gene delivery improved the targeting of mesenchymal stem cells to an injury site

Multitargeting Peptide-Functionalized Star-Shaped Copolymers with Comblike Structure and a POSS-Core to Effectively Transfect Endothelial Cells.

CAGW and TAT‐NLS Peptides Functionalized Multitargeting Gene Delivery System with High Transfection Efficiency

Nanovector for Gene Transfection and MR Imaging of Mesenchymal Stem Cells.